Illumina因基因测序技术面临10x Genomics提起的专利诉讼 - MSN
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - MSN
生物技术与制药领域的最新动态
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - MSN
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - Technology Networks
CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals - nutritioninsight.com
Illumina's Steve Barnard Provides an Update on the Company’s Unfolding Multiomics Strategy - GEN - Genetic Engineering and Biotechnology News
10x sues rival Illumina over gene-sequencing patents - Reuters
Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials - Business Wire
Clinical Advisory Board - Illumina
10X Genomics to integrate analysis tools into Anthropic's Claude for Life Sciences - Seeking Alpha
10x Genomics (NASDAQ: TXG) teams with Anthropic to bring single cell analysis to Claude - Stock Titan
Why Is 10x Genomics (TXG) Stock Rocketing Higher Today - Yahoo Finance
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences - PR Newswire
GBCC and Lonza partner for apprenticeship program - NH Business Review
OpenAI and Thermo Fisher Scientific partner to speed up drug development using AI - EdTech Innovation Hub
10x Genomics (TXG): Assessing Valuation After Recent Share Price Volatility - Yahoo Finance
Diwali marks Illumina’s exciting year ahead - Illumina
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet - BioSpace
What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation - Yahoo Finance
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI - BioSpace
Lonza expands its GMP solutions for cell and gene therapy - SelectScience